- Home
- CNDT vs CRVS Comparison
CNDT vs CRVS Comparison
Compare CNDT & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNDT
- CRVS
- Stock Information
- Founded
- CNDT 2016
- CRVS 2014
- Country
- CNDT United States
- CRVS United States
- Employees
- CNDT N/A
- CRVS N/A
- Industry
- CNDT Business Services
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- CNDT Consumer Discretionary
- CRVS Health Care
- Exchange
- CNDT Nasdaq
- CRVS Nasdaq
- Market Cap
- CNDT 628.4M
- CRVS 516.0M
- IPO Year
- CNDT N/A
- CRVS 2016
- Fundamental
- Price
- CNDT $4.04
- CRVS $5.01
- Analyst Decision
- CNDT Buy
- CRVS Strong Buy
- Analyst Count
- CNDT 1
- CRVS 5
- Target Price
- CNDT $9.00
- CRVS $12.38
- AVG Volume (30 Days)
- CNDT 1.0M
- CRVS 1.6M
- Earning Date
- CNDT 02-12-2025
- CRVS 11-12-2024
- Dividend Yield
- CNDT N/A
- CRVS N/A
- EPS Growth
- CNDT N/A
- CRVS N/A
- EPS
- CNDT 2.20
- CRVS N/A
- Revenue
- CNDT $3,509,000,000.00
- CRVS N/A
- Revenue This Year
- CNDT N/A
- CRVS N/A
- Revenue Next Year
- CNDT N/A
- CRVS N/A
- P/E Ratio
- CNDT $1.84
- CRVS N/A
- Revenue Growth
- CNDT N/A
- CRVS N/A
- 52 Week Low
- CNDT $2.96
- CRVS $1.30
- 52 Week High
- CNDT $4.59
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- CNDT 50.17
- CRVS 37.72
- Support Level
- CNDT $3.74
- CRVS $4.60
- Resistance Level
- CNDT $4.17
- CRVS $6.47
- Average True Range (ATR)
- CNDT 0.15
- CRVS 0.39
- MACD
- CNDT -0.01
- CRVS 0.03
- Stochastic Oscillator
- CNDT 59.80
- CRVS 21.93
About CNDT Conduent Incorporated
Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).